Your browser is out of date
With an updated browser, you will have a better Medtronic website experience. Update my browser now.
This map shows locations of centers offering advanced therapies for Bladder and/or Bowel Control (including Sacral Neuromodulation).
† Under expected therapy settings and telemetry use
‡ Anticholinergic/antimuscarinic medication.
§ Under certain conditions; see approved labeling for details. Patients with InterStim™ SureScan™ MRI leads only.
Patton V, Wiklendt L, Arkwright JW, et al. The effect of sacral nerve stimulation on distal colonic motility in patients with fecal incontinence. Br J Surg. 2013;100(7):959–968.
Leng WW, Morrisroe SN. Sacral nerve stimulation for the overactive bladder. Urol Clin N Am. 2006;33:491–501.
Chancellor MB, Chartier-Kastler EJ. Principles of sacral nerve stimulation (SNS) for the treatment of bladder and urethral sphincter dysfunctions. Neuromod. 2000;3(1):15–26.
Siegel S, Noblett K, Mangel J, et al. Results of a prospective, randomized, multicenter study evaluating sacral neuromodulation with InterStim™ therapy compared to standard medical therapy at six months in subjects with mild symptoms of overactive bladder. Neurourol Urodyn. 2015;34:224–230.
Chohan N, Hilton P, Brown K, Dixon L. Efficacy and duration of response to botulinum neurotoxin A (onabotulinumA) as a treatment for detrusor overactivity in women. Int Urogynecol J Pelvic Floor Dysfunct. 2015;26(11):1605-1612.
InterStim Implant Numbers, version 2.0, July-2023
The information presented on this website is for information purposes only. It is not intended to replace a consultation with a healthcare professional.